NCT05402501

Brief Summary

The LIMS study is an observational study that investigates the effectiveness of an online lifestyle program for patients with multiple sclerosis (MS). The patients will be monitored during 27 months, starting 3 months prior to the start of the lifestyle program.

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
900

participants targeted

Target at P75+ for all trials

Timeline
Completed

Started Apr 2021

Typical duration for all trials

Geographic Reach
1 country

1 active site

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

April 15, 2021

Completed
1 year until next milestone

First Submitted

Initial submission to the registry

April 19, 2022

Completed
1 month until next milestone

First Posted

Study publicly available on registry

June 2, 2022

Completed
2.4 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

November 1, 2024

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

November 1, 2024

Completed
Last Updated

June 2, 2022

Status Verified

May 1, 2022

Enrollment Period

3.6 years

First QC Date

April 19, 2022

Last Update Submit

May 30, 2022

Conditions

Keywords

Lifestyle

Outcome Measures

Primary Outcomes (1)

  • Multiple Sclerosis Impact Scale (MSIS-29)

    Questionnaire that measures the impact of MS on their daily functioning

    Change over time between baseline and follow-up time-points will be compared to change over time between the run-in period and baseline.

Secondary Outcomes (17)

  • 12-item Short Form Health Survey (SF-12)

    Assessed at 7 time-points during 27 months | Change over time between baseline and follow-up time-points will be compared to change over time between the run-in period and baseline.

  • EuroQol 5 Dimensions Questionnaire (EQ-5D)

    Assessed at 7 time-points during 27 months | Change over time between baseline and follow-up time-points will be compared to change over time between the run-in period and baseline.

  • BMI

    Assessed at 7 time-points during 27 months Change over time between baseline and follow-up time-points will be compared to change over time between the run-in period and baseline.

  • Waist circumference

    Assessed at 7 time-points during 27 months | Change over time between baseline and follow-up time-points will be compared to change over time between the run-in period and baseline.

  • Bristol stool chart

    Assessed at 7 time-points during 27 months | Change over time between baseline and follow-up time-points will be compared to change over time between the run-in period and baseline.

  • +12 more secondary outcomes

Study Arms (1)

Patients with multiple sclerosis (MS)

Patients will participate in an online lifestyle program organized by Voeding Leeft, which consists of four main topics: diet, physical activity, relaxation and sleep.

Behavioral: Lifestyle intervention program "Leef! met MS"

Interventions

The lifestyle program consists of a three-months intensive program, followed by a 21-months 'inspiration' program with occasional meetings.

Patients with multiple sclerosis (MS)

Eligibility Criteria

Age18 Years - 75 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

Patients with multiple sclerosis (MS) who signed up for the online lifestyle intervention of Voeding Leeft will be asked to participate in this observational study.

You may qualify if:

  • MS diagnosis
  • Motivated to adapt their lifestyle
  • Able to complete online questionnaires by themselves
  • Able to do grocery shopping and to (let someone) prepare the meals from the program
  • In a subpopulation (n=200): daily use of a smartphone

You may not qualify if:

  • Not able to participate in an online lifestyle intervention (e.g. not having an email address, laptop/computer, internet)
  • An inability to speak or read Dutch
  • Vegan diet
  • Not willing to eat fish
  • BMI \<18.5 and \>35 kg/m2
  • Pregnant or breastfeeding
  • Diagnosis of an eating disorder or psychiatric disorder (according to the DSM-V criteria)
  • History of bariatric surgery
  • Another disorder, such as inflammatory bowel disease (e.g. Crohn's disease or ulcerative colitis), cardiovascular disease (e.g. severe heart failure), malignancy, diabetes type 1 and 2
  • Having previously participated in a lifestyle intervention of Voeding Leeft or currently participating in another lifestyle program or lifestyle study.
  • Currently under treatment at a dietician or lifestyle coach

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Amsterdam UMC, location VUmc

Amsterdam, North Holland, 1081 HV, Netherlands

RECRUITING

MeSH Terms

Conditions

Multiple Sclerosis

Condition Hierarchy (Ancestors)

Demyelinating Autoimmune Diseases, CNSAutoimmune Diseases of the Nervous SystemNervous System DiseasesDemyelinating DiseasesAutoimmune DiseasesImmune System Diseases

Study Officials

  • Brigit de Jong

    Amsterdam UMC, location VUmc

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Brigit de Jong, Dr.

CONTACT

Ilse Nauta, Drs.

CONTACT

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Coordinating investigator

Study Record Dates

First Submitted

April 19, 2022

First Posted

June 2, 2022

Study Start

April 15, 2021

Primary Completion

November 1, 2024

Study Completion

November 1, 2024

Last Updated

June 2, 2022

Record last verified: 2022-05

Locations